Nothing Special   »   [go: up one dir, main page]

SE9101431L - Foerfarande foer framstaellning av furo-(3,4-c)-pyriinderivat i ickeracemisk form - Google Patents

Foerfarande foer framstaellning av furo-(3,4-c)-pyriinderivat i ickeracemisk form

Info

Publication number
SE9101431L
SE9101431L SE9101431A SE9101431A SE9101431L SE 9101431 L SE9101431 L SE 9101431L SE 9101431 A SE9101431 A SE 9101431A SE 9101431 A SE9101431 A SE 9101431A SE 9101431 L SE9101431 L SE 9101431L
Authority
SE
Sweden
Prior art keywords
compound
pyrine
furo
derivatives
procedure
Prior art date
Application number
SE9101431A
Other languages
English (en)
Other versions
SE510808C2 (sv
SE9101431D0 (sv
Inventor
C Eck
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of SE9101431D0 publication Critical patent/SE9101431D0/sv
Publication of SE9101431L publication Critical patent/SE9101431L/sv
Publication of SE510808C2 publication Critical patent/SE510808C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE9101431A 1990-05-14 1991-05-13 Förfarande för framställning av furo-(3,4-c)-pyridinderivat i icke-racematisk form genom hydrolys med ett esteras SE510808C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/523,238 US5130252A (en) 1990-05-14 1990-05-14 Resolution of furopyridine enantiomers and synthetic precursors thereof

Publications (3)

Publication Number Publication Date
SE9101431D0 SE9101431D0 (sv) 1991-05-13
SE9101431L true SE9101431L (sv) 1991-11-15
SE510808C2 SE510808C2 (sv) 1999-06-28

Family

ID=24084213

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9101431A SE510808C2 (sv) 1990-05-14 1991-05-13 Förfarande för framställning av furo-(3,4-c)-pyridinderivat i icke-racematisk form genom hydrolys med ett esteras

Country Status (32)

Country Link
US (1) US5130252A (sv)
JP (1) JPH05117277A (sv)
KR (1) KR910020015A (sv)
AR (1) AR247762A1 (sv)
AT (1) AT400445B (sv)
AU (1) AU642368B2 (sv)
BE (1) BE1007016A3 (sv)
CA (1) CA2042421C (sv)
CH (1) CH682488A5 (sv)
DE (1) DE4115681C2 (sv)
DK (1) DK88991A (sv)
DZ (1) DZ1499A1 (sv)
ES (1) ES2033574B1 (sv)
FI (1) FI97807C (sv)
FR (1) FR2661919B1 (sv)
GB (1) GB2244056B (sv)
GR (1) GR1001593B (sv)
HK (1) HK131993A (sv)
IE (1) IE65891B1 (sv)
IT (1) IT1248743B (sv)
LU (1) LU87935A1 (sv)
MA (1) MA22154A1 (sv)
MY (1) MY107567A (sv)
NL (1) NL194615C (sv)
NO (1) NO180308C (sv)
NZ (1) NZ238009A (sv)
OA (1) OA09352A (sv)
PT (1) PT97657B (sv)
SE (1) SE510808C2 (sv)
TN (1) TNSN91035A1 (sv)
TW (1) TW226998B (sv)
ZA (1) ZA913461B (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0221494D0 (en) * 2002-09-16 2002-10-23 Generics Uk Ltd Novel processes for the preparation of 1.3-dihydro-6-methylfuro (3,4-c) pyndin derivatives
US20110251396A1 (en) * 2003-07-17 2011-10-13 Gilead Sciences, Inc. Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
US20050043391A1 (en) * 2003-07-17 2005-02-24 Fong Benson M. Combination therapies for treatment of hypertension and complications in patients with diabetes or metabolic syndrome
US20060089374A1 (en) * 2003-07-17 2006-04-27 Glenn Cornett Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
GB2423927A (en) * 2003-08-29 2006-09-13 Cotherix Inc Combination Of Cicletanine And An Oral Antidiabetic And/Or Blood Lipid-Lowering Agent For Treating Diabetes And Metabolic Syndrome
US20060154959A1 (en) * 2005-01-13 2006-07-13 Navitas Pharma Combination therapies of cicletanine and carvedilol
CA2593793A1 (en) * 2005-01-05 2006-07-13 Medicure International Inc. Compounds and methods for regulating triglyceride levels
US20080096915A1 (en) * 2005-01-13 2008-04-24 Greenberg Traurig LLP Compositions for the treatment of metabolic disorders
US20070141174A1 (en) * 2005-01-13 2007-06-21 Navitas Pharma, Inc. Enantiomeric compositions of cicletanine, in combination with other agents, for the treatment of hypertension
US20070105817A1 (en) * 2005-11-09 2007-05-10 Jim Page Use of cicletanine and other furopyridines for treatment of systolic-predominant hypertension, isolated systolic hypertension, elevated pulse pressure, and general hypertension
WO2008085872A1 (en) * 2007-01-03 2008-07-17 Cornett Glenn V Cicletanine and pkc inhibitors in the treatment of pulmonary and cardiac disorders
EP2498605B1 (en) * 2009-10-29 2014-08-27 Merck Sharp & Dohme Corp. Diuretics

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN156817B (sv) * 1981-02-10 1985-11-09 Scras
US4985365A (en) * 1981-11-28 1991-01-15 Sumitomo Chemical Company, Ltd. Process for producing optically active benzyl alcohol compound
DE3378834D1 (en) * 1982-08-13 1989-02-09 Kanegafuchi Chemical Ind Process for production of optically active oxazolidinone derivative
IN160104B (sv) * 1983-04-05 1987-06-27 Scras
JPS59216590A (ja) * 1983-05-24 1984-12-06 Ube Ind Ltd 光学活性フエニルプロパルギルアルコ−ル誘導体の製法
GB8327817D0 (en) * 1983-10-18 1983-11-16 Scras 4-halo-furo-(3 4-c)-pyridine derivatives
GB8330517D0 (en) * 1983-11-16 1983-12-21 Scras 6-vinyl-furo-(3,4-c)pyridine derivatives
GB8330658D0 (en) * 1983-11-17 1983-12-29 Scras 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives
GB8402740D0 (en) * 1984-02-02 1984-03-07 Scras Furo-(3 4-c)-pyridine derivatives
JPS60224494A (ja) * 1984-04-24 1985-11-08 Nissan Chem Ind Ltd α−メチルベンジルアルコ−ル類の光学分割法
GB8414559D0 (en) * 1984-06-07 1984-07-11 Scras Pyridine derivatives
GB8427218D0 (en) * 1984-10-27 1984-12-05 Scras Pyridine derivatives
JPS61289899A (ja) * 1985-06-18 1986-12-19 Kanegafuchi Chem Ind Co Ltd 光学活性２−ハロ−１−フエニルエタノ−ルおよびそのエステルの製造法
US4916074A (en) * 1986-10-30 1990-04-10 Chisso Corporation Process for producing optically active compounds
JP2691986B2 (ja) * 1987-08-28 1997-12-17 チッソ株式会社 ピリジン骨格を有する光学活性化合物の製造法
DE3737335A1 (de) * 1987-11-04 1989-05-18 Basf Ag Verfahren zur herstellung eines biokatalysators und dessen verwendung zur razematspaltung
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
DE3990349T1 (de) * 1988-04-06 1990-04-26 Scras Stereospezifisches verfahren zur herstellung von enantiomeren von furo(3,4-c)pyridin, so erhaltene verbindungen und therapeutische zusammensetzungen auf basis dieser verbindungen
NL8801311A (nl) * 1988-05-20 1989-12-18 Stamicarbon Fenylglycidaatstereoisomeren, omzettingsprodukten daarvan met 2-nitrothiofenol en de bereiding van diltiazem.
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives
GB8917168D0 (en) * 1989-07-27 1989-09-13 Scras Asymmetric synthesis of furo(3,4-c)pyridine derivatives

Also Published As

Publication number Publication date
FI97807C (sv) 1997-02-25
FI912315A (sv) 1991-11-15
OA09352A (fr) 1992-09-15
CA2042421A1 (en) 1991-11-15
ES2033574B1 (es) 1994-02-01
PT97657A (pt) 1992-02-28
LU87935A1 (fr) 1992-03-03
BE1007016A3 (fr) 1995-02-21
NO911852L (no) 1991-11-15
AU7620091A (en) 1991-11-14
MY107567A (en) 1996-04-30
PT97657B (pt) 1998-09-30
JPH05117277A (ja) 1993-05-14
ITMI911255A1 (it) 1992-11-08
NZ238009A (en) 1992-11-25
GR1001593B (el) 1993-03-31
FR2661919B1 (fr) 1994-12-30
DK88991D0 (da) 1991-05-13
FR2661919A1 (fr) 1991-11-15
NO180308C (no) 1997-03-26
ZA913461B (en) 1992-02-26
NO180308B (no) 1996-12-16
DE4115681A1 (de) 1991-11-21
CH682488A5 (fr) 1993-09-30
ATA98291A (de) 1995-05-15
IE65891B1 (en) 1995-11-29
US5130252A (en) 1992-07-14
NL194615C (nl) 2002-09-03
KR910020015A (ko) 1991-12-19
SE510808C2 (sv) 1999-06-28
FI912315A0 (sv) 1991-05-13
HK131993A (en) 1993-12-10
MA22154A1 (fr) 1991-12-31
DK88991A (da) 1991-11-15
GB9109810D0 (en) 1991-06-26
ES2033574A1 (es) 1993-03-16
NL9100749A (nl) 1991-12-02
IE911628A1 (en) 1991-11-20
GB2244056B (en) 1993-08-11
FI97807B (sv) 1996-11-15
DE4115681C2 (de) 2003-10-30
AU642368B2 (en) 1993-10-14
GB2244056A (en) 1991-11-20
NO911852D0 (no) 1991-05-13
TNSN91035A1 (fr) 1992-10-25
ITMI911255A0 (it) 1991-05-08
GR910100180A (en) 1992-07-30
TW226998B (sv) 1994-07-21
DZ1499A1 (fr) 2004-09-13
CA2042421C (en) 2000-08-22
SE9101431D0 (sv) 1991-05-13
IT1248743B (it) 1995-01-26
NL194615B (nl) 2002-05-01
AR247762A1 (es) 1995-03-31
AT400445B (de) 1995-12-27

Similar Documents

Publication Publication Date Title
SE9101431L (sv) Foerfarande foer framstaellning av furo-(3,4-c)-pyriinderivat i ickeracemisk form
ATE40570T1 (de) Verfahren zur herstellung eines optisch aktiven 3-(3,4-dihydroxyphenyl)-serins und ein geschuetztes derivat davon.
ATE66474T1 (de) Verfahren zur herstellung von substituierten 3chinolincarbonsaeuren.
EP0264457A4 (en) PROCESS FOR PREPARING OPTICALLY ACTIVE CYCLOPROPANECARBOXYLIC ACIDS.
FI20001108A (sv) Förfarande för framställning av en racemisk cis-förening
SE8203580L (sv) Sett att framstella apovinkaminsyraestrar
ATE71383T1 (de) Verfahren zur herstellung von cephalosporinestern.
DE3578423D1 (de) Neue cephalosporine und verfahren zu ihrer herstellung.
DE69809888D1 (de) Verfahren zur Herstellung von alpha-Aminoketonen
DE59108464D1 (de) Verfahren zur Herstellung von Acylaminomethanphosphonsäuren
ATE8257T1 (de) Verfahren zur herstellung von 4-chinolinonen.
ATE60580T1 (de) Verfahren zur herstellung von estern.
EP0396839A3 (en) Naphthalenepropionic acid salts
ATE97657T1 (de) Verfahren zur herstellung von propionsaeurederivaten.
ATE10281T1 (de) Verfahren zur herstellung eines antibiotikums.
AU585703B2 (en) Process for the enzymatic resolution of racemic 2-amino- 1-alkanols
DE3851783D1 (de) Verfahren zur Herstellung von 6-[D(-)-alpha-(4-Äthyl-2,3-dioxo-1-piperazin-carboxamido)-phenylacetamido]penicillansäure.
GB2017103A (en) Cephalosporin analogues
DK521785A (da) Fremgangsmaade til fremstilling af halogenerede 3,3-dimethyl-5-hexan-2-oner
ATE11669T1 (de) Vasodilator, verfahren zur herstellung und arzneimittelzusammensetzungen.
KR880009898A (ko) (r)-2-하이드록시-4-페닐부티르산 및 에스테르의 제조 및 분리방법
JPS5536404A (en) New penicillanic acid derivative, its optically active isomer, its salt, and its preparation
FI822456L (fi) Foerfarande foer frramstaellning av penamderivat
DK74594A (da) Fremgangsmåde til fremstilling af paroxetin eller et farmaceutisk acceptabelt salt deraf

Legal Events

Date Code Title Description
NUG Patent has lapsed